News

Boston Scientific Showcases Innovations at Upcoming Healthcare Conference

Boston Scientific Showcases Innovations at Upcoming Healthcare Conference

Boston Scientific to Engage at UBS Global Healthcare Conference

Boston Scientific Corporation (NYSE: BSX) is set to participate in a significant upcoming event known as the UBS Global Healthcare Conference. This occasion highlights the company’s ongoing commitment to advancing medical technologies that enhance patient care worldwide.

Conference Highlights and Details

During the conference, scheduled for a Tuesday in mid-November, Boston Scientific will present insightful discussions led by key company figures. The participants include Nick Spadea-Anello, President of Electrophysiology, and Jon Monson, Senior Vice President of Investor Relations. Their session is expected to include a 35-minute question-and-answer segment, providing valuable insights for attendees.

Each participant will contribute their knowledge to engage with analysts, shedding light on the innovative strides Boston Scientific is making in the medical field. This live session will commence around 7:15 AM PT, around 10:15 AM ET, and will be available to those who wish to tune in.

Accessing the Live Webcast

A live webcast of this session will be accessible for those unable to attend in person, ensuring that interested parties can still engage with the information shared. Following the event, a replay will be available about an hour after the session concludes, allowing listeners to catch up on any missed discussions.

About Boston Scientific

Boston Scientific stands out in the medical technology field by transforming lives through pioneering solutions aimed at improving healthcare outcomes. With over 45 years of experience, the company has established itself as a global leader, developing a diverse portfolio designed to address various medical needs.

The company specializes in providing high-performance solutions that cover complex conditions across multiple specialties including cardiovascular, respiratory, gastrointestinal, oncology, neurology, and urology. Boston Scientific’s commitment to enhancing healthcare is evident through its range of innovative products designed to elevate patient treatment standards while aiming to reduce healthcare costs.

Innovative Medical Technologies

Boston Scientific's technologies are essential tools for healthcare providers. Their devices and therapies assist healthcare professionals in diagnosing and treating various diseases, directly impacting patient health outcomes. As the industry evolves, so does Boston Scientific, continually seeking to meet the unmet needs of patients through effective innovations.

Contacts for More Information

For further inquiries, you may contact: Chanel Hastings, Media Relations at +1 (508) 382-0288. Another key contact in Investor Relations is Jon Monson who can be reached at +1 (508) 683-5450.

Engaging with Boston Scientific through their official channels provides additional insights into their innovative products and ongoing projects. This engagement is crucial for staying updated with the company’s advancements and contributions to healthcare.

Frequently Asked Questions

What is the purpose of the UBS Global Healthcare Conference?

The conference serves to bring together healthcare professionals, investors, and key opinion leaders to discuss innovations and developments in the medical technology sector.

Who from Boston Scientific will be speaking at the conference?

Boston Scientific’s participants include Nick Spadea-Anello and Jon Monson, who will share insights into the company’s innovative healthcare solutions.

How can I access the live session of the conference?

The live session will be available via a webcast accessible through Boston Scientific's investor relations page.

What types of medical conditions does Boston Scientific address?

Boston Scientific’s technologies span various medical conditions, including cardiovascular, respiratory, gastrointestinal, and more, providing comprehensive solutions for healthcare providers.

How can I get in touch with Boston Scientific for more information?

You can reach out to their media relations team or investor relations department for any inquiries regarding the company and its innovative medical technologies.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Fermi's Leadership Saga: Proxy Wars and Power Struggles

Updated Category News Views 61

Unfolding the Drama at Fermi (NASDAQ:FRMI) You'd think you were watching a suspense drama unfold, not an annual shareholder meeting report. The co-founder of Fermi, Toby Neugebauer, stepped into the spotlight, throwing shade at Rick Perry and the board's shaky status quo. Pitting Shareholders Against the Board Neugebauer isn't mincing words about the current state of...

Continue Reading
Senstar Boasts Robust Q3 Growth Amid Global Demand

Updated Category News Views 83

A Standout Quarter for Senstar Technologies How often do you see a company jumping 37% in revenue year-over-year? Not every day, that’s for sure. But that's exactly what's happening with Senstar Technologies Corporation (NASDAQ: SNT). For the third quarter of 2026, they've pulled in $13.1 million compared to last year’s $9.5 million. And that's not just some fluke –...

Continue Reading
Research Solutions Set to Reveal Q1 FY27 Results

Updated Category News Views 89

Understanding the Stakes Ahead of RSSS's Earnings Call Aw, the sweet suspense of earnings season. Research Solutions, Inc. (NASDAQ: RSSS) has circled November 12, 2026, as the date to let investors in on its numbers for the first quarter of fiscal year 2027. A date that's gotta have the folks over at RSSS feeling like it’s judgment day. You know how it goes—market...

Continue Reading
Key Life Events That Demand a Financial Plan Change

Updated Category News Views 49

Navigating Life's Milestones with Financial Savvy Nothing stirs the financial pot quite like life's big events. The grind of daily life might trick you into thinking everything's fine, but ignore these milestones at your peril. Ted Thatcher, a financial advisor from Roseville, California, lays it out in HelloNation's latest foray into sound financial planning: your...

Continue Reading
Encompass Health Faces Uncertain Future with Sea Pines

Updated Category News Views 55

Unexpected Downpour Closes Sea Pines They say when it rains, it pours. That's not just true in life, but as it happens, it's quite literal in Melbourne, Florida. A deluge of biblical proportions forced an immediate lockdown of the Sea Pines Rehabilitation Hospital. Flooded to the gills, this once stalwart institution finds its doors shuttered indefinitely. It's a...

Continue Reading
Array Digital's Q3 2026 Earnings: Strategic Wins and Challenges

Updated Category News Views 36

From Towers to Earnings: Array Digital's 2026 Path Array Digital Infrastructure, Inc. (NYSE:AD) just rolled out its Q3 2026 numbers, and honestly, it's a mixed bag. This company is one of those handy barometers for the telecom infrastructure market, especially now that it's a full-blown tower company. They've pitched an earnings call for the early birds at 9 a.m. CT...

Continue Reading
Deep Principle's Hydrogen-1.0: A Leap in AI-Driven Chemistry

Updated Category News Views 101

Leaving Old Lab Notebooks in the Dust Deep Principle just shook up the science lab with their latest brainchild, Hydrogen-1.0. We're talking about an AI-driven marvel designed to tackle chemistry and materials research like no traditional lab rat ever could. On November 4, they rolled out this bad boy—an open-weight model fine-tuned to turn vague scientific hunches into...

Continue Reading
S&P 500 Drop: A Market Glitch or Future Trend?

Updated Category News Views 34

A Sudden Jolt in a Trending Market Mornings like these make you question your coffee strength. A major market dip, with the S&P 500 shedding 3.51%, is like a slap to the face, especially when the Nasdaq Composite takes a 5.24% nosedive. The Dow isn't spared, dropping 2.45%. But, let's not lose our heads here. Today is a blip, a pixel in the bigger picture where the S&P...

Continue Reading
UP Fintech Faces 25% Stock Drop Amid Fraud Suit

Updated Category News Views 67

Stock Market Whiplash: UP Fintech's Rough Ride You know, just when you think you've seen it all in this bonkers stock market world, something like a 25% drop in UP Fintech’s stock reminds you that surprises never end. Now, UP Fintech’s facing a class action lawsuit, alleging it didn’t exactly play fair, sparking this latest rollercoaster ride. Yeah, buckle up folks,...

Continue Reading
Gildan Class Action: What Investors Should Know

Updated Category News Views 9

Playing Hardball: Gildan Faces Serious Claims Gildan Activewear Inc. (NYSE:GIL) isn't just dealing with wardrobe malfunctions; it's knee-deep in a class action lawsuit that's got investors on edge. The allegations? Accusations of deceptive practices like channel stuffing, which supposedly jazzed up their financials by moving unsold products through distribution channels...

Continue Reading

Top 5 Most Recently Viewed Articles

Americas CarMart Sees Director Buy Shares Amid Company Changes

Updated Category News Views 124

Director's Stock Purchase at Americas CarMart Americas CarMart Inc. (NASDAQ: CRMT) has recently caught the public's attention as director Ann G. Bordelon purchased shares worth $52,976. This acquisition signals a strong confidence in the used car dealership's ability to face the competitive market and continue on its path toward growth and success. The Acquisition Details...

Continue Reading
Scully Royalty Reports Half-Year Results and announces Dividend

Updated Category News Views 94

Scully Royalty Ltd. Half-Year Financial Report Insights Scully Royalty Ltd. (NYSE: SRL) has recently published its half-year report, detailing its financial results for the six months concluded. The report, referred to as the Half-Year Report, reflects the company's business performance and strategic updates. Dividend Declaration and Financial Performance In conjunction...

Continue Reading
Inozyme Pharma's 2024 Financial Update and Future Focus

Updated Category News Views 154

Inozyme Pharma's Strategic Vision for 2024 Inozyme Pharma, Inc. (NASDAQ: INZY) is making significant strides as it navigates the dynamic landscape of biotechnology. The company specializes in developing breakthrough therapeutics tailored for rare diseases impacting bone health and vascular function. As of December 31, 2024, Inozyme announced its financial results...

Continue Reading
Strategy Inc Partners with Snowflake for AI Data Solutions

Updated Category News Views 245

Strategy Inc and Snowflake Team Up for Enhanced Data Management Strategy Inc (NASDAQ: MSTR) has announced its partnership with Snowflake Inc (NYSE: SNOW) to establish a more standardized framework for managing data effectively. This collaboration aims to simplify and streamline the data landscape through the Open Semantic Interchange (OSI) Advancing Open Data Standards As...

Continue Reading
Innovative Industrial Properties Faces Legal Challenges Ahead

Updated Category News Views 129

Innovative Industrial Properties Legal Challenges Shareholders of Innovative Industrial Properties, Inc. (NYSE: IIPR) are currently navigating a troubling period as the company faces a lawsuit for securities law violations. This situation raises important questions for investors who may be affected. Class Period and Allegations The allegations against IIPR highlight...

Continue Reading